Hydroquinone: Optimizing therapeutic outcomes in the clinical setting of melanin-related hyperpigmentation

Today's Therapeutic Trends

Volumn 19, Issue 3, 2001, Pages 191-203

  Draelos, Z D ^a  

^a DERMATOLOGY CONSULTING SERVICES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; GLYCOLIC ACID; HYDROQUINONE; LUSTRA; MELANIN; RETINOIC ACID; SUNSCREEN;

DRUG EFFICACY; DRUG FORMULATION; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG SAFETY; DRUG STRUCTURE; HUMAN; HYPERPIGMENTATION; REVIEW; TREATMENT OUTCOME;

EID: 0035184606     PISSN: 07412320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. A lifetime of healthy skin: Implications for women
2. Introduction. The magnitude of skin disease in the United States
3. Procedures for skin diseases performed by physicians in 1993 and 1994: Analysis of data from the National Ambulatory Medical Care Survey
4. The quality of life in acne: A comparison with general medical conditions using generic questionnaires
5. Quality of life assessments in dermatology
6. Patient-physician consensus on quality of life in dermatology
7. Coping with acne vulgaris. Evaluation of the chronic skin disorder questionnaire in patients with acne
8. The effectiveness of acne treatment: An assessment by patients of the outcome of therapy
9. Responsiveness of the dermatology-specific quality of life (DSQL) instrument to treatment for acne vulgaris in a placebo-controlled clinical trial
10. Evaluation of clinical efficacy and safety of adapalene 0.1% gel versus tretinoin 0.025% gel in the treatment of acne vulgaris, with particular reference to the onset of action and impact on quality of life
11. Acne vulgaris and the quality of life of adult dermatology patients
12. Dowling oration 2000. Dermatology patients: What do they really need?
13. The health impact of solar radiation and prevention strategies. Report of the Environmental Council, American Academy of Dermatology
14. Sun exposure, skin cancers and related skin conditions
15. The aging face and skin
16. Exogenous ochronosis: An epidemiological study
17. Exogenous ochronosis: An overview
18. Cutaneous absorption and clinical effect of ascorbyl palmitate and tocopherol acetate antioxidants in Lustra® (hydroquinone USP 4%)
19. The effectiveness and safety of Lustra® (hydroquinone USP 4%) in dyschromia
20. Evaluation of Lustra® (hydroquinone USP 4%) on the skin's antioxidant system
21. Topical retinoic acid for treatment of solar damage
22. Topical tretinoin for treatment of photo damaged skin. A multicenter study
23. Tretinoin emollient cream: A new therapy for photo damaged skin
24. Study of hydroquinone USP 4%, 0.05% tretinoin, and in combination in UV-induced dyschromia with actinic photodamage
25. The use of hydroquinone with facial laser resurfacing
26. Conquer hyperpigmentation after laser resurfacing
27. Efficacy of hydroquinone cream (USP 4%) used alone or in combination with salicylic acid peels in improving photodamage on the neck and upper chest